NCT06790420 2026-05-15RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database StudyPfizerCompleted2,703 enrolled 13 charts
NCT01062074 2017-04-17GARDASIL Reexamination Study (V501-059)Merck Sharp & Dohme LLCCompleted3,605 enrolled 6 charts